FindTrial
Sign In

Pharmaceutical Care in Management of MDR-TB Patients.

Role of Pharmaceutical Care Management among MDR-TB Patients: A Prospective Interventional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048857
Enrollment
160
Registered
2023-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J42- Unspecified chronic bronchitis

Interventions

Intervention1: Related to QOL Related to DRPs : Counselling will be given to the patients to Resolve the DRPs Improve HRQOL( Health related quality of life) Intervention2: nil: nil Intervention3: NI

Sponsors

Government Of Karnataka
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient on MDR-TB treatment Patient with age >= 18 years Patient with chronic diseases Patients who completed with 6month Pulmonary-TB treatment regimen.

Exclusion criteria

Exclusion criteria: Patients who are not willing to participate Patients who are under 6-month Pulmonary-TB treatment regimen Special population like pediatrics, pregnant and lactating women. Patients interfere with loss to follow up.

Design outcomes

Primary

MeasureTime frame
Assessment of Risk factors among MDR-TB patients Resolving various Drug Related Problems Improvement of Quality Of Life of the patientTimepoint: 1 month—

Secondary

MeasureTime frame
Intervention will be given to patients to improve Quality Of LifeTimepoint: 2 month—

Countries

India

Contacts

Public ContactVishwa Rajakumar Byakod

Head Of the Department, KLE College of Pharmacy, Belagavi.

msganachari@gmail.com9448634457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026